Two sulfated glycans have been proved to exhibit notably high capacity for the classification of both rheumatoid factor (RF)-positive and negative RA patients, as well as anti-citrullinated protein antibodies (ACPA)-positive and negative RA patients, showing notable and specific value of N-glycan as biomarkers for RA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.